Clinical Trial Update: Ultramicronized PEA (Normast) in Spinal Cord Injury Neuropathic Pain [NA]

View source ↗

Summary

A clinical trial evaluating ultramicronized palmitoylethanolamide (Normast) for neuropathic pain after spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Normast (Ultramicronized palmitoylethanolamide) (palmitoylethanolamide)

Snippet

Sponsor: Danish Pain Research Center | Conditions: Neuropathic Pain, Spinal Cord Injury | NA | Status: COMPLETED